Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
What Exactly Can Meta’s Muse Do And Where Should We Draw the Line?
Christopher Zara, News Director at Fast Company, explains what Meta’s Muse can actually do and whether its growing access to our lives goes too far.
The CLARITY Act Stalled: What Does It Mean For Crypto Investors?
Ryan Louvar, Chief Policy Officer and Head of Business and Legal Affairs, Digital Assets at WisdomTree, breaks down the CLARITY Act and crypto’s next phase.
The 2026 Gadgets You’ll Want To Know Before 2027
Mark Spoonauer, Global Editor-in-Chief of Tom’s Guide, reveals the year’s biggest tech winners, from Apple’s MacBook Neo to free in-flight Wi-Fi.
Is Your Portfolio All Wrong? Peter Lazaroff On Building The “Perfect” Portfolio
Peter Lazaroff, author of The Perfect Portfolio and host of The Long-Term Investor Podcast, shares how investors can cut through market noise.
Smarter, Not Just Faster: How Embraer Bets on the Future of Flight
Inside Embraer's newest jet, the Praetor 600E: a first-of-its-kind Smart Window, a $7 billion order, and a bet on a new generation of private flyers
KFC Is Reinventing Itself: Inside the Bold New "Open House" Concept
KFC U.S. President Catherine Tan-Gillespie breaks down Open House, the new hospitality-first concept meant to reinvent the Colonel for today's consumers.
